Clinical Trial: End Stage Liver Disease and Body Composition Assessment: Utilizing Bioelectric Impedance Analysis (BIA)
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: End Stage Liver Disease and Body Composition Assessment: Utilizing Bioelectric Impedance Analysis (BIA)
Brief Summary: The purpose of this research study is to see how effective bioelectric impedance analysis (BIA) is in determining body composition (the amount of fat versus muscle in the body) and nutritional status in patients with End Stage Liver Disease (ESLD)
Detailed Summary:
The aim of this study is to report the validity of mBIA to determine body composition changes pre and post LVP (Large Volume Paracentesis)
- 18 years of age or older
- Cirrhotic patients with refractory ascites requiring LVP (a treatment to remove large volumes of excess fluid from the abdominal cavity)
- End Stage Liver Disease
Sponsor: University of Cincinnati
Current Primary Outcome: Efficacy and utility of BIA in determining body composition and nutritional status using multi-frequency machines in patients with ESLD and ascites requiring LVP. [ Time Frame: Before and after large volume paracentesis ]
Original Primary Outcome: Efficacy and utility of BIA in determining body composition and nutritional status using multi-frequency machines in patients with ESLD and ascites requiring LVP.
Current Secondary Outcome: Quantify the difference in BIA pre and post LVP to evaluate the impact of oncotic pressure in the assessment of total body composition. [ Time Frame: Before and after large volume paracentis ]
Original Secondary Outcome: Quantify the difference in BIA pre and post LVP to evaluate the impact of oncotic pressure in the assessment of total body composition.
Information By: University of Cincinnati
Dates:
Date Received: September 8, 2006
Date Started: September 2006
Date Completion:
Last Updated: March 3, 2011
Last Verified: March 2011
